{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T09:51:29Z","timestamp":1742637089372},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Shenzhen Science and Technology Bureau in China","award":["20110119"],"award-info":[{"award-number":["20110119"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.thromres.2014.04.018","type":"journal-article","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T01:17:21Z","timestamp":1398734241000},"page":"440-448","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cardiac-targeting transfection of tissue-type plasminogen activator gene to prevent the graft thrombosis and vascular anastomotic restenosis after coronary bypass"],"prefix":"10.1016","volume":"134","author":[{"given":"Jun","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-An","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Ping","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.thromres.2014.04.018_bb0005","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jvs.2012.12.069","article-title":"Local drug delivery to prevent restenosis","volume":"57","author":"Seedial","year":"2013","journal-title":"J Vasc Surg"},{"issue":"5","key":"10.1016\/j.thromres.2014.04.018_bb0010","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/SLA.0b013e318288c38d","article-title":"Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions","volume":"257","author":"Harskamp","year":"2013","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.thromres.2014.04.018_bb0015","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jcin.2011.05.014","article-title":"Saphenous vein graft intervention","volume":"4","author":"Lee","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.thromres.2014.04.018_bb0020","first-page":"519","article-title":"Why is the mammary artery so special and what protects it from atherosclerosis?","volume":"2","author":"Otsuka","year":"2013","journal-title":"Ann Cardiothorac Surg"},{"issue":"8","key":"10.1016\/j.thromres.2014.04.018_bb0025","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s11748-009-0413-5","article-title":"Irradiation inhibits vascular anastomotic stenosis in a canine model","volume":"57","author":"Saito","year":"2009","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.thromres.2014.04.018_bb0030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ahj.2013.01.019","article-title":"Saphenous vein graft failure and clinical outcomes: toward a surrogate end point in patients following coronary artery bypass surgery?","volume":"165","author":"Harskamp","year":"2013","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.thromres.2014.04.018_bb0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/jocs.12075","article-title":"Gene therapy for vein graft failure","volume":"28","author":"Wang","year":"2013","journal-title":"J Card Surg"},{"issue":"5","key":"10.1016\/j.thromres.2014.04.018_bb0040","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.thromres.2011.05.021","article-title":"Safety of coronary artery bypass surgery during therapeutic oral anticoagulation","volume":"128","author":"Airaksinen","year":"2011","journal-title":"Thromb Res"},{"issue":"8","key":"10.1016\/j.thromres.2014.04.018_bb0050","doi-asserted-by":"crossref","first-page":"736","DOI":"10.5543\/tkda.2012.26790","article-title":"Saphenous vein graft disease: causes, prevention, and ontemporary treatment strategies","volume":"40","author":"G\u00f6kay","year":"2012","journal-title":"Turk Kardiyol Dern Ars"},{"issue":"3","key":"10.1016\/j.thromres.2014.04.018_bb0055","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.thromres.2008.05.007","article-title":"Biological and pharmacological aspects of perioperative hemorrhagic complications associated with oral platelet-directed antithrombotic agents. Focus on isolated coronary artery bypass grafting and oral irreversible P2Y(12) receptor antagonists","volume":"123","author":"Becker","year":"2009","journal-title":"Thromb Res"},{"issue":"8","key":"10.1016\/j.thromres.2014.04.018_bb0060","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/hrt.2004.036178","article-title":"Mid-term outcome and quality of life after aortic valve replacement in elderly people: mechanical versus stentless biological valves","volume":"91","author":"Florath","year":"2005","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.thromres.2014.04.018_bb0065","doi-asserted-by":"crossref","first-page":"220","DOI":"10.5090\/kjtcs.2011.44.3.220","article-title":"Relationship between the occurrence of thromboembolism and INR measurement interval in low intensity anticoagulation after aortic mechanical valve replacement","volume":"44","author":"Rhie","year":"2011","journal-title":"Korean J Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.thromres.2014.04.018_bb0070","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11239-011-0621-6","article-title":"Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro study","volume":"32","author":"Kaeberich","year":"2011","journal-title":"J Thromb Thrombolysis"},{"issue":"Suppl. 2","key":"10.1016\/j.thromres.2014.04.018_bb0075","doi-asserted-by":"crossref","first-page":"e89S","DOI":"10.1378\/chest.11-2293","article-title":"Antiplatelet Drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Eikelboom","year":"2012","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.thromres.2014.04.018_bb0080","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.thromres.2014.01.038","article-title":"Bivalirudin use during percutaneous coronary intervention in patients on chronic warfarin therapy","volume":"133","author":"Kiviniemi","year":"2014","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.thromres.2014.04.018_bb0085","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2174\/138161212799277716","article-title":"Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agents","volume":"18","author":"Pamukcu","year":"2012","journal-title":"Curr Pharm Des"},{"issue":"Suppl. 2","key":"10.1016\/j.thromres.2014.04.018_bb0090","doi-asserted-by":"crossref","first-page":"e601S","DOI":"10.1378\/chest.11-2302","article-title":"Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Lansberg","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2014.04.018_bb0095","doi-asserted-by":"crossref","first-page":"173124","DOI":"10.1155\/2012\/173124","article-title":"Aspirin: pharmacology and clinical applications","volume":"2012","author":"Paez Espinosa","year":"2012","journal-title":"Thrombosis"},{"issue":"4","key":"10.1016\/j.thromres.2014.04.018_bb0100","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jvs.2009.06.017","article-title":"Randomized controlled trial of aspirin and clopidogrel versus aspirin and placebo on markers of smooth muscle proliferation before and after peripheral angioplasty","volume":"50","author":"Wilson","year":"2009","journal-title":"J Vasc Surg"},{"issue":"7","key":"10.1016\/j.thromres.2014.04.018_bb0105","first-page":"522","article-title":"Analysis on the risk factors of intracardial thrombus after prosthetic valve replacement: a 1-year follow-up study","volume":"48","author":"Wang","year":"2010","journal-title":"Zhonghua Wai Ke Za Zhi"},{"issue":"7","key":"10.1016\/j.thromres.2014.04.018_bb0110","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s12010-010-8979-z","article-title":"Cloning and expression of functional full-length human tissue plasminogen activator in Pichia pastoris","volume":"162","author":"Majidzadeh","year":"2010","journal-title":"Appl Biochem Biotechnol"},{"issue":"4","key":"10.1016\/j.thromres.2014.04.018_bb0115","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/BF00215671","article-title":"Allelic dimorphism in the human tissue-type plasminogen activator (TPA) gene as a result of an Alu insertion\/deletion event","volume":"88","author":"Ludwig","year":"1992","journal-title":"Hum Genet"},{"issue":"7","key":"10.1016\/j.thromres.2014.04.018_bb0120","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1074\/jbc.M111.317719","article-title":"A high affinity interaction of plasminogen with fibrin is not essential for efficient activation by tissue-type plasminogen activator","volume":"287","author":"Kim","year":"2012","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.thromres.2014.04.018_bb0125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/SLA.0b013e31821221b1","article-title":"Trauma, shock, and disseminated intravascular coagulation: lessons from the classical literature","volume":"254","author":"Gando","year":"2011","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.thromres.2014.04.018_bb0130","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1358\/dot.2011.47.7.1600191","article-title":"Recombinant tissue-type plasminogen activators: \u201ctime matters\u201d","volume":"47","author":"Kunadian","year":"2011","journal-title":"Drugs Today (Barc)"},{"issue":"3","key":"10.1016\/j.thromres.2014.04.018_bb0135","first-page":"163","article-title":"The medicolegal issue of tissue plasminogen activator in ischemic stroke: a review of judiciary decrees in Taiwan","volume":"20","author":"Chen","year":"2011","journal-title":"Acta Neurol Taiwan"},{"issue":"4","key":"10.1016\/j.thromres.2014.04.018_bb0140","first-page":"511","article-title":"Construction and biological activities of human tPA eukaryotic expression plasmid","volume":"3","author":"Wu","year":"2004","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"6","key":"10.1016\/j.thromres.2014.04.018_bb0145","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0741-5214(95)70223-7","article-title":"Retroviral vector-mediated transfer and expression of human tissue plasminogen activator gene in human endothelial and vascular smooth muscle cells","volume":"21","author":"Ekhterae","year":"1995","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1016\/j.thromres.2014.04.018_bb0150","first-page":"132","article-title":"Experimental study on construction of recombinant t-PA gene plasmid to prevent the thrombosis after mechanical valve replacement","volume":"12","author":"Ji","year":"2006","journal-title":"South China J Cardiovasc Dis"},{"issue":"14","key":"10.1016\/j.thromres.2014.04.018_bb0155","first-page":"1683","article-title":"Transfection of tissue-type plasminogen activator gene to prevent vascular anastomotic restenosis after coronary bypass","volume":"17","author":"Ji","year":"2007","journal-title":"China J Mod Med"},{"issue":"1","key":"10.1016\/j.thromres.2014.04.018_bb0160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2003.10.009","article-title":"Albumin nanoparticles improved the stability, nuclear accumulation and anticytomegaloviral activity of a phosphodiester oligonucleotide","volume":"94","author":"Arnedo","year":"2004","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.thromres.2014.04.018_bb0165","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/oli.1.1999.9.301","article-title":"Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides","volume":"9","author":"Ayni\u00e9","year":"1999","journal-title":"Antisense Nucleic Acid Drug Dev"},{"issue":"29","key":"10.1016\/j.thromres.2014.04.018_bb0170","first-page":"5739","article-title":"Nano-carriers for the target treatment of tumor","volume":"13","author":"Wang","year":"2009","journal-title":"J Clin Rehabil Tissue Eng Res"},{"issue":"4","key":"10.1016\/j.thromres.2014.04.018_bb0175","first-page":"304","article-title":"Treatment of ultrasound contrast agents for gene or drug delivery","volume":"3","author":"Wang","year":"2006","journal-title":"Chin J Interv Imaging"},{"issue":"11","key":"10.1016\/j.thromres.2014.04.018_bb0180","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/RLI.0b013e3181e6f42f","article-title":"Optimal enhancement configuration of silica nanoparticles for ultrasound imaging and automatic detection at conventional diagnostic frequencies","volume":"45","author":"Casciaro","year":"2010","journal-title":"Invest Radiol"},{"issue":"4","key":"10.1016\/j.thromres.2014.04.018_bb0185","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1540-8175.2001.00349.x","article-title":"Therapeutic ultrasound for gene delivery","volume":"18","author":"Porter","year":"2001","journal-title":"Echocardiography"},{"issue":"2","key":"10.1016\/j.thromres.2014.04.018_bb0190","first-page":"127","article-title":"Recent advances in the applications of ultrasonic microbubbles as gene delivery systems","volume":"42","author":"Zhao","year":"2007","journal-title":"Yao Xue Xue Bao"},{"issue":"12","key":"10.1016\/j.thromres.2014.04.018_bb0195","first-page":"1359","article-title":"Progress of ultrasound microbubble contrast agent with gene and drug targeting therapy","volume":"17","author":"Lao","year":"2007","journal-title":"J Med Imaging"},{"issue":"12","key":"10.1016\/j.thromres.2014.04.018_bb0200","first-page":"1456","article-title":"Albumin nanoparticles used as gene carrier","volume":"21","author":"Zhang","year":"2004","journal-title":"Chin J Exp Surg"},{"issue":"34","key":"10.1016\/j.thromres.2014.04.018_bb0205","first-page":"178","article-title":"Construction of plasminogen activator and its expressive activity in human umbilical vein endothelial cells","volume":"9","author":"Yang","year":"2005","journal-title":"Chin J Clin Rehabil"},{"issue":"11","key":"10.1016\/j.thromres.2014.04.018_bb0210","first-page":"859","article-title":"Study on the preparation of a new sugar albumin microbubble ultrasound contrast agent","volume":"36","author":"Du","year":"2001","journal-title":"Yao Xue Xue Bao"},{"issue":"7","key":"10.1016\/j.thromres.2014.04.018_bb0215","first-page":"493","article-title":"Study for preparing specific targeted ultrasound contrast agent","volume":"23","author":"Li","year":"2007","journal-title":"Chin J Ultrasound Med"},{"issue":"2","key":"10.1016\/j.thromres.2014.04.018_bb0220","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cmpb.2011.12.005","article-title":"Numerical analysis of coronary artery bypass grafts: an over view","volume":"108","author":"Owida","year":"2012","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.thromres.2014.04.018_bb0225","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.jacc.2004.08.064","article-title":"Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a department of veterans affairs cooperative study","volume":"44","author":"Goldman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2014.04.018_bb0230","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1378\/chest.88.3.341","article-title":"Morphologic changes in long-term saphenous vein bypass grafts","volume":"88","author":"Atkinson","year":"1985","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.thromres.2014.04.018_bb0235","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/1708538113478737","article-title":"Chitosan nanoparticle carrying small interfering RNA to platelet-derived growth factor B mRNA inhibits proliferation of smooth muscle cells in rabbit injured arteries","volume":"21","author":"He","year":"2013","journal-title":"Vascular"},{"issue":"22","key":"10.1016\/j.thromres.2014.04.018_bb0240","first-page":"3233","article-title":"A antisenes oligonucleatide targeting against PDGF-B mRNA inhibits proliferation of smooth muscle cells in injured rabbit arteries after denudation","volume":"18","author":"Ji","year":"2008","journal-title":"China J Mod Med"},{"issue":"10","key":"10.1016\/j.thromres.2014.04.018_bb0245","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/gt.2013.20","article-title":"Inhibition of neointimal hyperplasia in a rabbit vein graft model following non-viral transfection with human iNOS cDNA","volume":"20","author":"Meng","year":"2013","journal-title":"Gene Ther"},{"issue":"1","key":"10.1016\/j.thromres.2014.04.018_bb0250","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pharmthera.2012.07.002","article-title":"Prevention of coronary in-stent restenosis and vein graft failure: does vascular gene therapy have a role?","volume":"136","author":"Robertson","year":"2012","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.thromres.2014.04.018_bb0255","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jss.2010.01.011","article-title":"Study on construction of nano-tPA plasmid to prevent thrombosis after mechanical valve replacement in dogs","volume":"168","author":"Ji","year":"2011","journal-title":"J Surg Res"},{"issue":"5","key":"10.1016\/j.thromres.2014.04.018_bb0260","first-page":"2622265","article-title":"Preparation and immunological characterization of mitoxantrone-loaded immuno-nanoparticles against human hepatoma","volume":"16","author":"Liu","year":"2000","journal-title":"Chin J Immunol"},{"key":"10.1016\/j.thromres.2014.04.018_bb0265","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2147\/IJGM.S25027","article-title":"An elevated D-dimer value: a burden on our patients and hospitals","volume":"5","author":"Chopra","year":"2012","journal-title":"Int J Gen Med"},{"issue":"7","key":"10.1016\/j.thromres.2014.04.018_bb0270","first-page":"703","article-title":"Parameters related to fibrinolysis and their meanings","volume":"59","author":"Urano","year":"2011","journal-title":"Rinsho Byori"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814002321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814002321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T15:23:18Z","timestamp":1538666598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384814002321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0049384814002321"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2014.04.018","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac-targeting transfection of tissue-type plasminogen activator gene to prevent the graft thrombosis and vascular anastomotic restenosis after coronary bypass","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2014.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}